E-ISSN: 2319-3387 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access
Research and Reviews: Journal of Oncology and Hematology [2319-3387(e)]Â is a peer-reviewed open access journal launched in 2012 focused on the publication of current research work carried out at all the major research centers in the fields of Oncology and Haematology
rrjooh maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Institutional Profile Link: https://aiimsbhubaneswar.nic.in/facultyDirectory.aspx
Journal: Research and Reviews: Journal of Oncology and Hematology
Modern healthcare systems are being improved by artificial intelligence (AI) and machine learning (ML), particularly in the treatment of cancer.
Cannabinoids, a complex class of lipophilic compounds found in Cannabis sativa L., are attracting significant clinical interest for their multifaceted therapeutic potential, particularly within oncology.
One of the main causes of cancer-related death globally is liver cancer, and improving patient outcomes depends heavily on early detection.
Primary plasma cell leukemia (pPCL) is a rare and aggressive plasma cell dyscrasia, defined by ≥5% circulating plasma cells, with poor prognosis and rapid progression.
Lung cancer is a global killer because it’s often found late.
The tumor microenvironment (TME) plays a pivotal role in cancer initiation, progression, and therapeutic response.
